Literature DB >> 7563191

Lack of vesicant injury following extravasation of liposomal doxorubicin.

S Madhavan, D W Northfelt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7563191     DOI： 10.1093/jnci/87.20.1556

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

Review 1.  Overview, prevention and management of chemotherapy extravasation.

Authors:  Firas Y Kreidieh; Hiba A Moukadem; Nagi S El Saghir
Journal:  World J Clin Oncol       Date:  2016-02-10

2.  Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol.

Authors:  Ursula Pluschnig; Werner Haslik; Günther Bayer; Afschin Soleiman; Rupert Bartsch; Wolfgang Lamm; Günther G Steger; Christoph C Zielinski; Robert M Mader
Journal:  Support Care Cancer       Date:  2014-11-30       Impact factor: 3.603

Review 3.  Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma.

Authors:  A J Coukell; C M Spencer
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

Review 4.  Safety aspects of pegylated liposomal doxorubicin in patients with cancer.

Authors:  D S Alberts; D J Garcia
Journal:  Drugs       Date:  1997       Impact factor: 9.546

5.  Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies.

Authors:  K J Harrington; G Rowlinson-Busza; K N Syrigos; P S Uster; R M Abra; J S Stewart
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

6.  Preparation, pharmacokinetics, biodistribution, antitumor efficacy and safety of Lx2-32c-containing liposome.

Authors:  Hongbo Wang; Jianqiao Zhang; Guangyao Lv; Jinbo Ma; Pengkai Ma; Guangying Du; Zongliang Wang; Jingwei Tian; Weishuo Fang; Fenghua Fu
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

7.  Extravasation of pegylated-liposomal doxorubicin: favorable outcome after immediate subcutaneous administration of corticosteroids.

Authors:  Ayako Mitsuma; Masataka Sawaki; Takashi Shibata; Sachi Morita; Megumi Inada; Tomoya Shimokata; Mihoko Sugishita; Koichi Kitagawa; Masaki Sawada; Akihiro Nawa; Yuichi Ando
Journal:  Nagoya J Med Sci       Date:  2012-02       Impact factor: 1.131

8.  Anthracycline extravasation injuries: management with dexrazoxane.

Authors:  Karin Jordan; Timo Behlendorf; Franziska Mueller; Hans-Joachim Schmoll
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.